| Products | Indication | Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | BE | NDA | Pre-clinical | Partnership | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patented Biopharmaceutical Products | |||||||||||
| Metabolic | |||||||||||
| Bogutai® | Osteoporosis |
|
|
|
|
|
|
|
|
Self-R&D | 乐虎lehu国际: |
| UOS003(oral PTH) | Osteoporosis |
|
|
|
|
|
|
|
|
Self-R&D | 乐虎lehu国际: |
| Uni-GLP-1(liquid) | Type 2 Diabetes |
|
|
|
|
|
|
|
|
Self-R&D | 乐虎lehu国际: |
| Uni-GLP-1(liquid) | Obesity |
|
|
|
|
|
|
|
|
Self-R&D | 乐虎lehu国际: |
| UDS003(oral GLP-1) | Type 2 Diabetes |
|
|
|
|
|
|
|
|
Self-R&D | 乐虎lehu国际: |
| Ophthalmology | |||||||||||
| UB101 | AMD |
|
|
|
|
|
|
|
|
 |
乐虎lehu国际: |
| UB102 | AMD |
|
|
|
|
|
|
|
|
|
|
| Wound Care | |||||||||||
| UB104 | Wound Healing |
|
|
|
|
|
|
|
|
 |
乐虎lehu国际: |
| Products | Discovery | Production Development | Formulation Development | Marketed | Partnership | Details | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Advanced Skincare Raw Materials | |||||||||||
| Fibronectin |
|
|
|
|
 |
乐虎lehu国际: | |||||
| Beauty peptides |
|
|
|
|
|
乐虎lehu国际: | |||||
| Collagen |
|
|
|
|
|
乐虎lehu国际: | |||||
| Microecological skin-care |
|
|
|
|
|
乐虎lehu国际: | |||||
| Stem cell exosome |
|
|
|
|
 |
乐虎lehu国际: | |||||
| Product | Indication | Information survey | Preliminary preparations | Research on prescription technology |
Quality research | Stability study | Pharmacology and Toxicology Research |
ANDA | Marketed | Remark | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| High Value Generic Drugs | |||||||||||
| Endocrinology | |||||||||||
| Diquafosol sodium eye drops | Dry eye |
|
|
|
|
|
|
|
|
API Manufacturer | 乐虎lehu国际: |
| Patented Biopharmaceutical Products | |||||
| Metabolic | |||||
Products |
Bogutai® |
UOS003 (oral PTH) |
Uni- GLP-1 (liquid) |
Uni- GLP-1 (liquid) |
UDS003 (oral GLP-1) |
| Indication | Osteoporosis | Osteoporosis | Type 2 Diabetes |
Obesity | Type 2 Diabetes |
| Discovery |
|
|
|
|
|
| Pre-clinical |
|
|
|
|
|
| Phase 1 |
|
|
|
|
|
| Phase 2 |
|
|
|
|
|
| Phase 3 |
|
|
|
|
|
| BE |
|
|
|
|
|
| NDA |
|
|
|
|
|
| Time to Market |
|
|
|
|
|
| Partnership | Self-R&D | Self-R&D | Self-R&D | Self-R&D | Self-R&D |
| Details | 乐虎lehu国际: | 乐虎lehu国际: | 乐虎lehu国际: | ||
| Ophthalmology | Wound Care | ||
Products |
UB101 |
UB102 |
UB104 |
| Indication | AMD | AMD | Wound Healing |
| Discovery |
|
|
|
| Pre-clinical |
|
|
|
| Phase 1 |
|
|
|
| Phase 2 |
|
|
|
| Phase 3 |
|
|
|
| BE |
|
|
|
| NDA |
|
|
|
| Time to market |
|
|
|
| Partnership | |
|
|
| Details | 乐虎lehu国际: | 乐虎lehu国际: | 乐虎lehu国际: |
| Advanced Skincare Raw Materials | |||||
Products |
Fibron- ectin |
Beauty peptides |
Collagen |
Microeco- logical skin-care |
Stem cell exosome |
| Discovery |
|
|
|
|
|
| Production Development |
|
|
|
|
|
| Formulation Development |
|
|
|
|
|
| Time to market |
|
|
|
|
|
| Partnership | |
|
|
|
|
| Details | 乐虎lehu国际: | 乐虎lehu国际: | 乐虎lehu国际: | 乐虎lehu国际: | 乐虎lehu国际: |
| High Value Generic Drugs | |
| Ophthalmology | |
Products |
Diquafosol sodium eye drops |
| Indication | Dry eye |
| Information survey |
|
| Preliminary preparations |
|
| Research on prescription technology |
|
| Quality research |
|
| Stability study |
|
| Pharmacology and Toxicology Research |
|
| ANDA |
|
| Time to market |
|
| Partnership | API Manufacturer |
| Details | 乐虎lehu国际: |
